NDC 42549-513

NDC 42549-513

NDC 42549-513 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 42549-513
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 42549-513-12 [42549051312]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA077937
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-10-05
Marketing End Date2010-03-08

NDC 42549-513-56 [42549051356]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-24
Inactivation Date2019-11-13

NDC 42549-513-60 [42549051360]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-10-05
Inactivation Date2019-11-13

NDC 42549-513-30 [42549051330]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-10-05
Inactivation Date2019-11-13

NDC 42549-513-02 [42549051302]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-24
Inactivation Date2019-11-13

NDC 42549-513-90 [42549051390]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-10-05
Inactivation Date2019-11-13

NDC 42549-513-28 [42549051328]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA078428
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-11-24
Inactivation Date2019-11-13

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.